Filing Details
- Accession Number:
- 0001415889-21-003112
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-06-21 16:10:31
- Reporting Period:
- 2021-06-18
- Accepted Time:
- 2021-06-21 16:10:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 861838 | Idera Pharmaceuticals Inc. | IDRA | Biological Products, (No Disgnostic Substances) (2836) | 043072298 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1318485 | B Daniel Soland | C/O Idera Pharmaceuticals, Inc. 505 Eagleview Boulevard, Suite 212 Exton PA 19341 | Chief Operating Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-06-18 | 50,000 | $1.19 | 78,843 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
